Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- BAVA.CO
- Price
- 189.40
- Stock movement up
- +0.35 (0.19%)
- Company name
- Bavarian Nordic
- Exchange
- (CO ,
- Currency
- DKK )
- Sector
- Healthcare >Biotechnology
- Markedsværdi
- 14.82B
- Ent værdi
- 14.73B
- Pris/omsætning
- 2.15
- Pris/bog
- 1.13
- Udbytte afkast
- -
- Udbyttevækst
- -
- Vekst år
- -
- FCF-udbetaling
- -
- Efterfølgende P/E
- 6.06
- Fremtidig P/E
- 19.39
- PEG
- -
- EPS-vekst
- -
- 1 års afkast
- -1.64%
- 3 års afkast
- -
- 5 års afkast
- -
- 10 års afkast
- -
Senest opdateret: 2025-12-10
UDBYTTE
BAVA.CO betaler ikke udbytte
VÆRDIANSÆTTELSE
Værdiansættelsesforhold
Loading...
Værdiansættelsesforhold-data
| Efterfølgende P/E | 6.06 |
| Pris til OCF | 4.73 |
| Pris til FCF | 11.55 |
| Pris til EBITDA | 8.08 |
| EV i forhold til EBITDA | 8.03 |
Værdiansættelse (salg/bogført værdi)
Loading...
Værdiansættelse (salg/bogført værdi)-data
| Pris til omsætning | 2.15 |
| Pris til egenkapital | 1.13 |
| EV i forhold til salg | 2.14 |
ØKONOMI
Pr. aktie
Loading...
Data pr. aktie
| Aktuelt antal aktier | 78.24M |
| EPS (TTM) | - |
| FCF pr. aktie (TTM) | - |
Resultatopgørelse
Loading...
Resultatopgørelse-data
| Omsætning (TTM) | - |
| Bruttofortjeneste (TTM) | - |
| Driftsindkomst (TTM) | - |
| Nettoindkomst (TTM) | - |
| EPS (TTM) | - |
| EPS (1 år frem) | 9.77 |
Marginer
Loading...
Marginer-data
| Bruttomargin (TTM) | - |
| Driftsmargin (TTM) | - |
| Fortjenstmargin (TTM) | - |
Balance
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
| Kontanter | 2.09B |
| Nettotilgodehavender | 1.23B |
| Omsætningsaktiver i alt | 6.89B |
| Goodwill | 0.00 |
| Immaterielle aktiver | 6.02B |
| Ejendomme, anlæg og udstyr | 2.19B |
| Sum aktiver | 15.16B |
| Kreditor | 1.10B |
| Kortfristet/nuværende langsigtet gæld | 0.00 |
| Summen af kortfristede forpligtelser | 1.80B |
| Sum gæld | 2.00B |
| Aktionærernes egenkapital | 13.16B |
| Materielle nettoaktiver | 0.00 |
Likviditet
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
| Likviditet fra driften (TTM) | - |
| Investeringsudgifter (TTM) | - |
| Fri pengestrøm (TTM) | - |
| Udbetalt udbytte (TTM) | - |
Finansiel indkomst
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
| Egenkapitalafkast | - |
| Afkast af aktiver | - |
| Afkast af investeret kapital | - |
| Kontant afkast af investeret kapital | - |
INFORMATION OM AKTIER
Aktiediagram
Loading...
Aktiekurs-data
| Åbning | 189.30 |
| Daglig høj | 190.05 |
| Daglig lav | 188.15 |
| Daglig volumen | 164K |
| Højeste gennem alle tider | 401.70 |
| 1 års analytiker estimat | - |
| Beta | 1.10 |
| EPS (TTM) | - |
| Udbytte pr. aktie | 0.00 |
| Ex-div dato | - |
| Næste dato for resultatpræsentation | 12 Mar 2026 |
Nedsidepotensial
Loading...
Nedsidepotensial-data
| BAVA.CO | S&P500 | |
| Nuværende prisfald fra top notering | -52.85% | - |
| Højeste prisfald | -65.11% | -19.00% |
| Højeste efterår dato | 7 Apr 2025 | 8 Apr 2025 |
| Gennemsnitlig fald fra toppen | -51.37% | -2.66% |
| Gennemsnitlig tid til nyt højdepunkt | - | 6 days |
| Maks. tid til nyt højdepunkt | 294 days | 89 days |
OPLYSNINGER OM VIRKSOMHEDEN
Markedsværdi
14.82B
Markedsværdi kategori
Large-cap
Beskrivelse
Bavarian Nordic A/S develops, manufactures, and supplies life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; Vaxchora, an oral vaccine for immunization against cholera; and Vivotif/Typhoral, an oral vaccine for immunization against typhoid fever. It is also developing MVA-BN WEV for the treatment of encephalitis viruses. It operates in the United States, Denmark, Canada, France, Germany, Singapore, Finland, Netherlands, Switzerland, Sweden, Taiwan, Saudi Arabia, Belgium, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.
Personale
1738
Hjemmeside
Investor relationer
-
SEC-indsendelser
Adm. direktør
Land
Denmark
By
Aktietype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...
FORSTÅ FORRETNINGEN
Loading...
NYHEDER OM VIRKSOMHEDEN
Alle nyhederPressemeddelelser
COPENHAGEN, Denmark, December 2, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced its intent to launch a one-time share buy-back program of up to DKK 500 million to be executed over the next 12 ...
2. december 2025
If you have ever wondered whether Bavarian Nordic is trading at a bargain or slipping past fair value, you are not alone. Let's dig in together and see what's really going on with this stock. While Ba...
28. november 2025
COPENHAGEN, Denmark, November 26, 2025 – Bavarian Nordic A/S invites its shareholders for a meeting and dialogue with the company’s board and management, who will provide the state of business and giv...
26. november 2025
Bavarian Nordic AS (BVNKF) reports a 32% revenue increase, driven by robust vaccine sales, while navigating public preparedness and market challenges.
14. november 2025
COPENHAGEN, Denmark, November 14, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results for the first nine months of 2025 and business progress for the third quarter of ...
14. november 2025
COPENHAGEN, Denmark, November 13, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that Chair of the Board, Luc Debruyne has decided to step down from the board with immediate effect. The Board ...
13. november 2025
Bavarian Nordic (CPSE:BAVA) shares have caught the attention of investors lately, as the stock has seen mixed trading activity over the past month. With price swings and a changing outlook, some are e...
11. november 2025
COPENHAGEN, Denmark, November 10, 2025 – Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley t...
10. november 2025
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION COP...
6. november 2025
COPENHAGEN, Denmark, November 1, 2025 – Bavarian Nordic A/S hereby issues the following clarification regarding the Health Emergency Preparedness and Response Authority (HERA) framework agreement, ann...
1. november 2025
Næste side